Results 181 to 190 of about 60,310 (240)

Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke. [PDF]

Eur J Neurol
Dong W, Lu Y, Long J, Peng Y, Ju Z, Xu T, Zhang Y, Zhai G, Zhong C.   +8 more
europepmc   +1 more source

The human colon: Evidence for degenerative changes during aging and the physiological consequences

Neurogastroenterology &Motility, EarlyView.
Reduced nociceptor innervation can explain diminished abdominal pain among the elderly. Degenerative changes occur within the colon wall, especially ascending colon. Mechanisms may include senescence‐like activity and inflammaging. Constipation is more likely to occur during age‐related challenges affecting functions of the bowel that now have reduced ...
Nicholas Baidoo, Gareth J. Sanger
wiley   +1 more source

GLP-1R/NPY2R regulate gene expression, ovarian and adrenal morphology in HFD mice. [PDF]

J Endocrinol
Khan D, Sridhar A, Moffett CR.
europepmc   +1 more source

Gastric and sacral electrical stimulation for motility disorders—A clinical perspective

Neurogastroenterology &Motility, EarlyView.
Abstract Background Electrical stimulation of the gut has been investigated in recent decades with a view to treating various gastro‐intestinal motility disorders including, among others, gastric electrical stimulation to relieve nausea and vomiting associated with gastroparesis and sacral neuromodulation to treat fecal incontinence and/or constipation.
Charlotte Desprez, Anne‐Marie Leroi, Guillaume Gourcerol   +2 more
wiley   +1 more source

GPCR Sense Communication Among Interaction Nematodes with Other Organisms. [PDF]

Int J Mol Sci
Wang J, Guo C, Wei X, Pu X, Zhao Y, Xu C, Wang W.   +6 more
europepmc   +1 more source

Central mechanisms of emesis: A role for GDF15

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Nausea and emesis are ubiquitously reported medical conditions and often present as treatment side effects along with polymorbidities contributing to detrimental life‐threatening outcomes, such as poor nutrition, lower quality of life, and unfavorable patient prognosis.
Tito Borner, Allison M. Pataro, Bart C. De Jonghe   +2 more
wiley   +1 more source

Structural insights into the selective recognition of RF-amide peptides by neuropeptide FF receptor 2. [PDF]

EMBO Rep
Kim J, Hong S, Lee H, Lee HS, Park C, Kim J, Im W, Choi HJ.   +7 more
europepmc   +1 more source

Evidence‐based review and frontiers of migraine therapy

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Cyclic vomiting syndrome (CVS) is identified as one of the “episodic syndromes that may be associated with migraine,” along with benign paroxysmal torticollis, benign paroxysmal vertigo, and abdominal migraine. It has been proposed that CVS and migraine may share pathophysiologic mechanisms of hypothalamic activation and altered ...
Kaitlin A. Greene, Amy A. Gelfand, Larry Charleston IV   +2 more
wiley   +1 more source

Beyond incretins: targeting neurokinin receptors for obesity treatment. [PDF]

Signal Transduct Target Ther
Thor D, Prömel S.
europepmc   +1 more source

Endocannabinoid signaling in stress, nausea, and vomiting

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard   +2 more
wiley   +1 more source